Paper21980511
RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.
Clague J and 5 others. PLoS One, 2011. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. Papers, record 21980511. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21980511
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Mutational Analysis | Major topic |
| DNA-Binding Proteins | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Germ Cells | Major topic |
| Hereditary Breast and Ovarian Cancer Syndrome | Major topic |
| Mutation | Major topic |
| Pedigree | Major topic |
| Adult | |
| Aged | |
| BRCA1 Protein | |
| BRCA2 Protein | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R25 CA085771 | NCI NIH HHS | United States | R25CA085771 | PubMed and NIH |
| R25 CA85771 | NCI NIH HHS | United States | R25CA085771 | PubMed and NIH |
Source NIH RePORTER
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11034067 | Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. | Cancer Res | 2000 | https://conductscience.org/library/papers/11034067 | PubMed |
| 2 | 18034184 | Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. | Nat Rev Cancer | 2007 | https://conductscience.org/library/papers/18034184 | PubMed |
| 3 | 20723205 | RAD51C germline mutations in breast and ovarian cancer patients. | Breast Cancer Res | 2010 | https://conductscience.org/library/papers/20723205 | PubMed |
| 4 | 20400963 | Mutation of the RAD51C gene in a Fanconi anemia-like disorder. | Nat Genet | 2010 | https://conductscience.org/library/papers/20400963 | PubMed |
| 5 | 15917310 | BRCA1 and BRCA2 as ovarian cancer susceptibility genes. | Carcinogenesis | 2005 | https://conductscience.org/library/papers/15917310 | PubMed |
| 6 | 21537932 | A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/21537932 | PubMed |
| 7 | 15723711 | The RAD51 gene family, genetic instability and cancer. | Cancer Lett | 2005 | https://conductscience.org/library/papers/15723711 | PubMed |
| 8 | 20697805 | Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/20697805 | PubMed |
| 9 | 20400964 | Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. | Nat Genet | 2010 | https://conductscience.org/library/papers/20400964 | PubMed |
| 10 | 11744692 | RAD51C interacts with RAD51B and is central to a larger protein complex in vivo exclusive of RAD51. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11744692 | PubMed |
| 11 | 21750962 | Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/21750962 | PubMed |
| 12 | 14704354 | Domain mapping of the Rad51 paralog protein complexes. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/14704354 | PubMed |
| 13 | 21597919 | RAD51C germline mutations in Chinese women with familial breast cancer. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/21597919 | PubMed |
| 14 | 19056696 | A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. | Genome Res | 2009 | https://conductscience.org/library/papers/19056696 | PubMed |
| 15 | 20471405 | Rad51C is essential for embryonic development and haploinsufficiency causes increased DNA damage sensitivity and genomic instability. | Mutat Res | 2010 | https://conductscience.org/library/papers/20471405 | PubMed |
| 16 | 10749867 | Evidence for simultaneous protein interactions between human Rad51 paralogs. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10749867 | PubMed |
| 17 | 11459987 | Complex formation by the human RAD51C and XRCC3 recombination repair proteins. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11459987 | PubMed |
| 18 | 20610543 | Cancer statistics, 2010. | CA Cancer J Clin | 2010 | https://conductscience.org/library/papers/20610543 | PubMed |
| 19 | 17292821 | Ten genes for inherited breast cancer. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17292821 | PubMed |
| 20 | 12853621 | Region and amino acid residues required for Rad51C binding in the human Xrcc3 protein. | Nucleic Acids Res | 2003 | https://conductscience.org/library/papers/12853621 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42682019 | Distinct functions of mammalian RAD51 paralogs in genome maintenance. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42682019 | PubMed |
| 42625895 | RAD51C breast cancer-identified variants with attenuated homologous recombination function exhibit sensitivity to combined PARP1 and ATR inhibition. | NAR Cancer | 2026 | https://conductscience.org/library/papers/42625895 | PubMed |
| 40670332 | Comprehensive RAD51C ovarian cancer variant analysis uncouples homologous recombination and replicative functions. | Nat Commun | 2025 | https://conductscience.org/library/papers/40670332 | PubMed |
| 39299233 | High-resolution functional mapping of RAD51C by saturation genome editing. | Cell | 2024 | https://conductscience.org/library/papers/39299233 | PubMed |
| 38330859 | Variants in the first methionine of RAD51C are homologous recombination proficient due to an alternative start site. | DNA Repair (Amst) | 2024 | https://conductscience.org/library/papers/38330859 | PubMed |
| 37843130 | RAD51 paralogs synergize with RAD51 to protect reversed forks from cellular nucleases. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/37843130 | PubMed |
| 37347260 | A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37347260 | PubMed |
| 37253112 | Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C. | Cancer Res | 2023 | https://conductscience.org/library/papers/37253112 | PubMed |
| 36969410 | In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins. | ACS Omega | 2023 | https://conductscience.org/library/papers/36969410 | PubMed |
| 36474934 | Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients. | Cancer Manag Res | 2022 | https://conductscience.org/library/papers/36474934 | PubMed |
| 36434258 | Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG. | Eur J Hum Genet | 2023 | https://conductscience.org/library/papers/36434258 | PubMed |
| 35805770 | Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35805770 | PubMed |
| 35785170 | Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. | Front Oncol | 2022 | https://conductscience.org/library/papers/35785170 | PubMed |
| 35328658 | Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328658 | PubMed |
| 34764678 | CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/34764678 | PubMed |
| 33350171 | Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes. | Cancer Med | 2021 | https://conductscience.org/library/papers/33350171 | PubMed |
| 32359370 | BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases. | J Ovarian Res | 2020 | https://conductscience.org/library/papers/32359370 | PubMed |
| 32322110 | Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer. | Geburtshilfe Frauenheilkd | 2020 | https://conductscience.org/library/papers/32322110 | PubMed |
| 31905201 | Rad51 paralogs and the risk of unselected breast cancer: A case-control study. | PLoS One | 2020 | https://conductscience.org/library/papers/31905201 | PubMed |
| 31782267 | A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect. | Mol Genet Genomic Med | 2020 | https://conductscience.org/library/papers/31782267 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21980511
GET https://conductscience.org/api/papers/v1/21980511/references?page=2